الوصف
A new phase 3 trial (MANEUVER) investigates pimicotinib, a highly selective CSF-1R inhibitor, for unresectable tenosynovial giant cell tumour (TGCT). Part 1 results show promising anti-tumor activity with a manageable safety profile. In this video, authors of the trial describe MANEUVER and explain what this could mean for TGCT patients. Read the full article at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02602-9/fulltext?dgcid=youtube_video_lancet_maneuver-2026 Visit The Lancet at https://www.thelancet.com/?dgcid=youtube_video_lancet_maneuver-2026 * * * Continue this conversation on social! Follow us today at… https://TheLancet.bsky.social/ https://Facebook.com/TheLancetMedicalJournal https://Instagram.com/TheLancetGroup https://LinkedIn.com/company/The-Lancet
قد يعجبك أيضاً
- 1
ألبومDani Harper
Dani Harper · ١٢٬١٢٩ استماع
- 2
ألبومYoung Steez
Young Steez · ٧٬٥٨٩ استماع
- 3
ألبومRuido Blanco
Ruido Blanco · ٣٬٤٣١ استماع
- 4
ألبومWhat Now? with Trevor Noah
٨٬١٩٧ استماع
- 5
ألبومPABLO MORENO Radio
١٧٤ استماع
- 6
ألبومDiieklong KOB
Diieklong KOB · ٩٬٩٠٩ استماع
- 7
ألبومTelevision Radio
Television · ١٬٧٨١ استماع
- 8
ألبومCalabash Radio
Yoruba Andabo · ٥٬٤٣٥ استماع
- 9
ألبومEXTIZE Radio
٦٩٨ استماع
- 10
ألبومSandra Wolska
Sandra Wolska · ١٧٤ استماع
- 11
ألبومPrisma
Anima · ٧٬٨٨٩ استماع
- 12
ألبومSticking; Not Stuck
Chew · ٧٬٦٨٨ استماع